This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Acute Liver Failure After Administration of the Herbal Tranquilizer Kava-Kava (Piper methysticum)

Robert Bernhard Brauer, MD; Manfred Stangl, MD; Jörg Rudiger Siewert, MD; Rudolf Pfab, MD; and Karen Becker, MD

Published: February 15, 2003

Article Abstract

Sir: The chemistry and pharmacology of kava-kava (Piper methysticum) is unique among psycholeptic substances. The original kava drink is a suspension of lipid material in cold water used by native people for centuries and has not been linked with reports of liver failure. For commercial use, the lipid fraction is gained by alcoholic or acetonic extraction from the root of the kava plant. The extract is dried and pressed into tablets. The major proportion of the lipid components of the kava pyrone consists of 6 chemically well-defined compounds containing the 4-methoxy-2-pyrone ring system (dihydrokavain, dihydromethysticin, kavain, methysticin, desmethoxyyangonin, and yangonin). The different kava pyrones have partially anxiolytic, neuroleptic, sedative-hypnotic, anticonvulsive, muscle-relaxant, analgetic, and spasmolytic effects. A cumulative action of kava combined with alcohol, barbiturates, psychotropics, and muscle relaxants resulting in coma has been described. The exact knowledge of the psychopharmacology of kava is still incomplete.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 64

Quick Links: